dipyridamole has been researched along with B-Cell Chronic Lymphocytic Leukemia in 2 studies
Dipyridamole: A phosphodiesterase inhibitor that blocks uptake and metabolism of adenosine by erythrocytes and vascular endothelial cells. Dipyridamole also potentiates the antiaggregating action of prostacyclin. (From AMA Drug Evaluations Annual, 1994, p752)
dipyridamole : A pyrimidopyrimidine that is 2,2',2'',2'''-(pyrimido[5,4-d]pyrimidine-2,6-diyldinitrilo)tetraethanol substituted by piperidin-1-yl groups at positions 4 and 8 respectively. A vasodilator agent, it inhibits the formation of blood clots.
Excerpt | Relevance | Reference |
---|---|---|
"WSU-CLL cells, a fludarabine resistant B-cell chronic lymphocytic leukemia cell line, has been shown to exhibit enhanced sensitivity to 2-chlorodeoxyadenosine (2-CdA) following 48-72 h exposure to bryostatin 1." | 3.70 | Bryostatin 1-induced modulation of nucleoside transporters and 2-chlorodeoxyadenosine influx in WSU-CLL cells. ( Ahmad, I; Al-Katib, AM; Beck, FW; Liu, KZ; Mantsch, HH; Mohammad, RM; Wall, NR, 2000) |
"Two cases of Toxic Epidermal Necrolysis, with a previous history of drugs intake, and associated to a lymphoma and to a chronic lymphoid leukemia, are presented." | 1.29 | [Toxic epidermal necrolysis associated with lymphoproliferative syndromes. Anatomo-clinical study. Presentation of 2 cases]. ( Aguado Santos, A; Gomez Duaso, AJ; Ortiz Reina, S; Sanz Asenjo, A; Seoane Leston, JM, 1993) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Seoane Leston, JM | 1 |
Gomez Duaso, AJ | 1 |
Sanz Asenjo, A | 1 |
Ortiz Reina, S | 1 |
Aguado Santos, A | 1 |
Beck, FW | 1 |
Al-Katib, AM | 1 |
Ahmad, I | 1 |
Wall, NR | 1 |
Liu, KZ | 1 |
Mantsch, HH | 1 |
Mohammad, RM | 1 |
2 other studies available for dipyridamole and B-Cell Chronic Lymphocytic Leukemia
Article | Year |
---|---|
[Toxic epidermal necrolysis associated with lymphoproliferative syndromes. Anatomo-clinical study. Presentation of 2 cases].
Topics: Anesthetics; Dipyridamole; Fatal Outcome; Female; Humans; Insulin; Leukemia, Lymphocytic, Chronic, B | 1993 |
Bryostatin 1-induced modulation of nucleoside transporters and 2-chlorodeoxyadenosine influx in WSU-CLL cells.
Topics: Aged; Antineoplastic Agents; Biological Transport, Active; Bryostatins; Carrier Proteins; Cladribine | 2000 |